Based on specific requirements for manufacture of biologics finished dosage forms, Siegfried has new capabilities at its sterile sites in Irvine, California and Hameln, Germany.
Recognizing that assurance of highest quality, reducing project timelines and minimizing wastage of drug substance is of the utmost importance for our customers with projects in clinical and commercial phases, we have created two specific options at our facilities:
Both facilities utilize either stainless steel and disposable technologies for compounding and storage.
Our biologics services are highly appreciated by our customers. For example, in May 2017, we announced a strategic collaboration with Symphogen A/S Denmark.